Evaluation of the clinical benefit of permixon® and tamsulosin in severe BPH patients - PERMAL study subset analysis
Objective: To compare the efficacy of the lipido-sterolic extract of Serenoa repens, Permixon, to that of the α-blocker, tamsulosin, in the treatment of severe low urinary tract symptoms (LUTS) of benign prostatic hyperplasia (BPH). Methods: In a 12-month, double-blind, randomized study that showed...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | French |
| Published: |
2004
|